VDR and pancreatic neoplasm: Although in vitro studies have identified vitamin D and its receptor as potential targets for inhibiting pancreatic cancer development or progression, genetic studies to date have not identified an association between the 25(OH)D, the VDR, and pancreatic cancer [21, 22].